AzTrials
AzTrials

Dental AnxietyNCT07853014

Virtual Reality to Reduce Anxiety in Adults Having Lower Wisdom Tooth Surgery

A study testing Immersive Virtual Reality (Meta Quest 3) in people with Dental Anxiety and Mandibular Third Molar, run by Hanoi Medical University at 1 site in Vietnam.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record

Search all trials

Trial summary

This randomized controlled trial will evaluate whether immersive virtual reality can reduce anxiety in adults undergoing surgical removal of mandibular third molars under local anesthesia. A total of 120 participants will be assigned to either an immersive virtual reality group or a standard-care control group. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Dental Anxiety, Mandibular Third Molar
What is being tested?
Immersive Virtual Reality (Meta Quest 3)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteVietnam
Study dates
9 Jun 2026to 30 Jul 2027
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults aged 18 years or older. Indication for surgical removal of a mandibular third molar. Mandibular third molar with a Pederson difficulty score of 5 or higher on panoramic radiography.
  • General health status permitting oral surgery, with no current acute infection, swelling or acute pain at the surgical site.
  • Able and willing to provide written informed consent and comply with the study procedures and scheduled follow-up visits.

Who cannot join

  • Severe psychiatric disorder, severe dizziness or a history of significant motion sickness that may interfere with use of virtual reality.
  • Systemic medical conditions that do not permit surgical treatment, including uncontrolled cardiovascular disease, uncontrolled diabetes mellitus or current use of immunosuppressive medication.
  • Pregnancy or breastfeeding. Current or previous radiotherapy involving the maxillofacial region.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Van Thang Nguyen, DDS, MSc contact

+84 849999942

drthangvan@gmail.com

Vietnam1 site, 1 recruiting
  • School of Dentistry, Hanoi Medical University

    Hanoi, Hanoi

    Van Thang Nguyen, DDS, MSc, +84 849999942, drthangvan@gmail.com

    Recruiting

Other trials in Vietnam

About this study

Official title: Effect of Immersive Virtual Reality on Anxiety During Surgical Removal of Mandibular Third Molars in Adults: A Randomized Controlled Trial

This randomized controlled trial will evaluate whether immersive virtual reality can reduce anxiety in adults undergoing surgical removal of mandibular third molars under local anesthesia. A total of 120 participants will be assigned to either an immersive virtual reality group or a standard-care control group. Participants in the virtual reality group will use a Meta Quest 3 headset displaying relaxing natural scenery beginning 2-3 minutes before local anesthesia and continuing through completion of surgery. Both groups will undergo the same standardized surgical protocol. The primary outcome is state anxiety during surgery, assessed using the State-Trait Anxiety Inventory-State scale (STAI-S). Secondary outcomes include intraoperative pain and immediate postoperative satisfaction. Additional measures will assess postoperative pain, swelling, mouth opening, wound healing, analgesic use, adverse events and acceptability of virtual reality.

Read the detailed description

This is a single-center, parallel-group randomized controlled trial involving 120 adults scheduled for surgical removal of a mandibular third molar. Eligible participants will be stratified according to baseline trait anxiety (STAI-T <40 or ≥40). Within each stratum, treatment allocation will use a minimization procedure with a biased-coin probability of 0.80/0.20 to improve balance between groups with respect to dental anxiety measured by the Modified Dental Anxiety Scale, age, and sex. Allocation will be concealed using sequentially numbered, opaque, sealed envelopes.

Participants assigned to the experimental group will use an immersive virtual reality headset (Meta Quest 3) presenting relaxing natural scenery. The headset will be started approximately 2-3 minutes before administration of local anesthesia and will remain in use until completion of the final suture. Participants assigned to the control group will receive standard care without virtual reality.

All mandibular third molar surgeries will follow the same standardized surgical protocol. Participating surgeons will have at least 5 years of surgical experience and will receive protocol-specific training.

State anxiety will be assessed before surgery and immediately after surgery, within 5 minutes after the final suture, with the post-surgical assessment referring to the participant's anxiety experienced during the procedure. Participants will also be followed for postoperative pain, facial swelling, maximum mouth opening, wound healing, sensory disturbances, analgesic consumption, and postoperative complications.

Being tested
Immersive Virtual Reality (Meta Quest 3)
Keywords
Virtual Reality, Mandibular Third Molar, Third Molar Surgery, Oral Surgery, State-Trait Anxiety Inventory, Immersive Virtual Reality

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Immersive Virtual Reality (Meta Quest 3)Device

    Participants will wear a Meta Quest 3 virtual reality headset with integrated audio displaying relaxing natural scenery. The virtual reality intervention will begin approximately 2-3 minutes before administration of local anesthesia and will continue throughout the surgical procedure until completion of the final suture. The intervention may be discontinued if the participant experiences significant cybersickness, such as dizziness, nausea or discomfort

Study groups in NCT07853014
Study groupRoleWhat they receive
Immersive Virtual RealityExperimentalParticipants will receive immersive virtual reality using a Meta Quest 3 headset in addition to standardized surgical care during removal of a mandibular third molar
Receives: Device: Immersive Virtual Reality (Meta Quest 3)
Standard CareNo interventionParticipants will undergo the same standardized mandibular third molar surgical procedure without virtual reality beyond routine care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. State Anxiety During Surgery Measured by the State-Trait Anxiety Inventory-State (STAI-S)

    State anxiety associated with the surgical procedure will be assessed using the 20-item State-Trait Anxiety Inventory-State (STAI-S). The total score ranges from 20 to 80, with higher scores indicating greater state anxiety. Participants will self-complete the STAI-S within 5 minutes after the final suture as the standardized assessment of anxiety associated with the just-completed surgical procedure.

    Measured: Within 5 minutes after the final suture on the day of surgery

Secondary outcomes (2)
  1. Pain During Surgery Measured by a 0-10 Numeric Rating Scale

    Pain associated with the just-completed surgical procedure will be self-reported on a 0-10 numeric rating scale, where 0 indicates no pain and 10 indicates the worst pain imaginable. The assessment will be completed within 5 minutes after the final suture.

    Measured: Within 5 minutes after the final suture on the day of surgery

  2. Immediate Postoperative Satisfaction

    Participant-reported satisfaction with the surgical experience will be assessed using a 0-10 numeric rating scale, with higher scores indicating greater satisfaction.

    Measured: Within 5 minutes after completion of surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Oct 2026
  2. Study start9 Jun 2026
  3. Primary completion30 Jun 2027 (estimated)
  4. Study completion30 Jul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Two-arm parallel-group randomized controlled trial comparing immersive virtual reality plus standard surgical care with standard surgical care alone. Randomization is stratified by baseline STAI-T and uses covariate-adaptive minimization with a biased-coin probability of 0.80/0.20 to balance MDAS, age, and sex.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07853014
Sponsor's protocol ID
VR-M3-RCT-2026-01
Status last verified
Sep 2026
First submitted
25 Sep 2026
Last updated
1 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in